Study focus area

OUR STUDIES

TRANSPORTATION VULNERABILITY AS A BARRIER FOR PEOPLE NOT ENGAGED IN HIV MEDICAL CARE: MEASURING THE EFFECT OF TRADITIONAL TRANSPORTATION SERVICES VERSES CONCIERGE TRANSPORTATION SERVICES ON RETENTION IN CARE, VIRAL SUPPRESSION AND PATIENT SATISFACTION

Background

Patients in largely rural states, such as South Carolina, may benefit from free concierge transportation services due to the limited public transportation systems and substantial travel burdens in these areas. The University of South Carolina Medical Center’s Infectious Disease Clinic will determine the cost and effectiveness of Lyft transportation over traditional methods of transportation in increasing linkage to HIV care.

CMI Booklet image two guys hailing cab

Design

A hybrid type II stepped wedged design was used with a sample of 160 patients who have been out of care for more than 1 year. The sample was divided into two clusters of 80 participants. The first cluster was divided with an intervention group of 40 participants with Lyft transportation and a control group of 40 participants with traditional transportation. The second cluster served as a control group of traditional transportation. Clusters gradually transitioned to Lyft transportation with data analysis completed at 9-month intervals.

Primary Objectives

  • Measure virologic outcomes among patients utilizing concierge transportation over traditional transportation methods
  • Examine the differential implementation and effectiveness outcomes by patient residence and driving distance to the clinic
  • Assess the feasibility and related costs to expand this as a state-wide Ryan White supported program to partnering Ryan White grantees

Collaborators

Dr. Divya Ahuja

Dr. Sharon Weissman

Setting

University of South Carolina Medical Center Infectious Disease Clinic

Location

U.S.A.

Duration

Jan 2020 – Dec 2022

Category

Retention in Care and Adherence

Key study materials

ViiV study lead and contact

Tammeka Evans

Director of Global Public Health ad Innovation

Contact

RELATED STUDIES

USA

As part of this project, financial incentives were used to engage and retain people living with HIV with the goal of contributing to viral suppression in the Baton Rouge, LA area.

USA

As part of an effort to re-engage patients into care, this study determined the effectiveness of using an outreach nurse as a direct clinical liaison through the State Bridge Counsellor (SBC) Program

USA

This study investigates barriers and facilitators specifically among foreign and US born Spanish and English-speaking Latino MSM.

Our partnerships

Our partnerships

We are proud to partner with multiple organizations that work to prevent HIV and improve the lives of people who live with HIV.

Find out more

NP-GBL-HVU-WCNT- 210055 | March 2022

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.